279 related articles for article (PubMed ID: 16641262)
21. The critical role of proximal gag sequences in feline immunodeficiency virus genome encapsidation.
Kemler I; Azmi I; Poeschla EM
Virology; 2004 Sep; 327(1):111-20. PubMed ID: 15327902
[TBL] [Abstract][Full Text] [Related]
22. Mutations in matrix and SP1 repair the packaging specificity of a Human Immunodeficiency Virus Type 1 mutant by reducing the association of Gag with spliced viral RNA.
Ristic N; Chin MP
Retrovirology; 2010 Sep; 7():73. PubMed ID: 20825656
[TBL] [Abstract][Full Text] [Related]
23. Mutations in the Basic Region of the Mason-Pfizer Monkey Virus Nucleocapsid Protein Affect Reverse Transcription, Genomic RNA Packaging, and the Virus Assembly Site.
Dostálková A; Kaufman F; Křížová I; Kultová A; Strohalmová K; Hadravová R; Ruml T; Rumlová M
J Virol; 2018 May; 92(10):. PubMed ID: 29491167
[TBL] [Abstract][Full Text] [Related]
24. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.
Poon DT; Li G; Aldovini A
J Virol; 1998 Mar; 72(3):1983-93. PubMed ID: 9499052
[TBL] [Abstract][Full Text] [Related]
25. Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.
Kaye JF; Lever AM
J Virol; 1998 Jul; 72(7):5877-85. PubMed ID: 9621049
[TBL] [Abstract][Full Text] [Related]
26. Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.
Luban J; Goff SP
J Virol; 1994 Jun; 68(6):3784-93. PubMed ID: 8189516
[TBL] [Abstract][Full Text] [Related]
27. Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation.
D'Costa J; Brown HM; Kundra P; Davis-Warren A; Arya SK
J Gen Virol; 2001 Feb; 82(Pt 2):425-434. PubMed ID: 11161282
[TBL] [Abstract][Full Text] [Related]
28. The nucleocapsid domain is responsible for the ability of spleen necrosis virus (SNV) Gag polyprotein to package both SNV and murine leukemia virus RNA.
Certo JL; Kabdulov TO; Paulson ML; Anderson JA; Hu WS
J Virol; 1999 Nov; 73(11):9170-7. PubMed ID: 10516024
[TBL] [Abstract][Full Text] [Related]
29. Gag-Pol supplied in trans is efficiently packaged and supports viral function in human immunodeficiency virus type 1.
Hill MK; Hooker CW; Harrich D; Crowe SM; Mak J
J Virol; 2001 Aug; 75(15):6835-40. PubMed ID: 11435562
[TBL] [Abstract][Full Text] [Related]
30. Hydrophobic amino acids in the human immunodeficiency virus type 1 p2 and nucleocapsid proteins can contribute to the rescue of deleted viral RNA packaging signals.
Rong L; Russell RS; Hu J; Guan Y; Kleiman L; Liang C; Wainberg MA
J Virol; 2001 Aug; 75(16):7230-43. PubMed ID: 11461996
[TBL] [Abstract][Full Text] [Related]
31. Effects of a single amino acid substitution within the p2 region of human immunodeficiency virus type 1 on packaging of spliced viral RNA.
Russell RS; Roldan A; Detorio M; Hu J; Wainberg MA; Liang C
J Virol; 2003 Dec; 77(24):12986-95. PubMed ID: 14645555
[TBL] [Abstract][Full Text] [Related]
32. The role of nucleocapsid and U5 stem/A-rich loop sequences in tRNA(3Lys) genomic placement and initiation of reverse transcription in human immunodeficiency virus type 1.
Huang Y; Khorchid A; Gabor J; Wang J; Li X; Darlix JL; Wainberg MA; Kleiman L
J Virol; 1998 May; 72(5):3907-15. PubMed ID: 9557676
[TBL] [Abstract][Full Text] [Related]
33. Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.
Richardson JH; Child LA; Lever AM
J Virol; 1993 Jul; 67(7):3997-4005. PubMed ID: 8510213
[TBL] [Abstract][Full Text] [Related]
34. The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.
Shehu-Xhilaga M; Hill M; Marshall JA; Kappes J; Crowe SM; Mak J
J Virol; 2002 May; 76(9):4331-40. PubMed ID: 11932399
[TBL] [Abstract][Full Text] [Related]
35. On the Selective Packaging of Genomic RNA by HIV-1.
Comas-Garcia M; Davis SR; Rein A
Viruses; 2016 Sep; 8(9):. PubMed ID: 27626441
[TBL] [Abstract][Full Text] [Related]
36. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
37. Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation.
McBride MS; Schwartz MD; Panganiban AT
J Virol; 1997 Jun; 71(6):4544-54. PubMed ID: 9151848
[TBL] [Abstract][Full Text] [Related]
38. Deletion of stem-loop 3 is compensated by second-site mutations within the Gag protein of human immunodeficiency virus type 1.
Rong L; Russell RS; Hu J; Laughrea M; Wainberg MA; Liang C
Virology; 2003 Sep; 314(1):221-8. PubMed ID: 14517075
[TBL] [Abstract][Full Text] [Related]
39. Subcellular Localization of HIV-1
Becker JT; Sherer NM
J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 Sequence Necessary and Sufficient to Package Non-viral RNAs into HIV-1 Particles.
Liu Y; Nikolaitchik OA; Rahman SA; Chen J; Pathak VK; Hu WS
J Mol Biol; 2017 Aug; 429(16):2542-2555. PubMed ID: 28673553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
